PCN35 DEVELOPMENT AND VALIDATION OF A DISEASE-SPECIFIC, NEUROENDOCRINE TUMOR QUESTIONNAIRE (QOL-NET). TO MEASURE PATIENTS' PERCEPTION OF THE EFFECTS OF DISEASE ON THEIR QUALITY OF LIFE (QOL)

May 1, 2006, 00:00
10.1016/S1098-3015(10)64659-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)64659-1/fulltext
Title : PCN35 DEVELOPMENT AND VALIDATION OF A DISEASE-SPECIFIC, NEUROENDOCRINE TUMOR QUESTIONNAIRE (QOL-NET). TO MEASURE PATIENTS' PERCEPTION OF THE EFFECTS OF DISEASE ON THEIR QUALITY OF LIFE (QOL)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64659-1&doi=10.1016/S1098-3015(10)64659-1
First page :
Section Title :
Open access? : No
Section Order : 64
Categories :
Tags :
Regions :
ViH Article Tags :